| Annual Financials | 2021 | 2022 | 2023 | 2024 | TTM |
Revenue  | 37 | 56 | 50 | 41 | 0 |
| Expenses | 35 | 54 | 48 | 38 | 0 |
| EBITDA | 1 | 2 | 3 | 3 | 0 |
| Operating Profit % | 4 % | 4 % | 5 % | 6 % | 0 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 1 | 1 | 1 | 0 |
| Profit Before Tax | 1 | 2 | 2 | 1 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 1 | 1 | 1 | 1 | 0 |
| EPS in ₹ | 2.69 | 3.96 | 3.61 | 2.49 | 0.00 |
Saroja Pharma Industries
41.00
-4.00
(-8.89%)
Market Cap
16.50 Cr
EPS
2.49
PE Ratio
18.81
Dividend Yield
0.00 %
Industry
Chemicals52 Week High
70.75
52 Week Low
33.10
PB Ratio
1.13
Debt to Equity
0.81
Sector
Specialty Chemicals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
3,031.70 | #1 1,54,206.70 | 73.48 | 12,522.60 | 5.69 | #1 1,747 | 40.49 | 53.32 | |
2,900.20 | 85,969.10 | 68.72 | 13,221.50 | -11.53 | 1,336 | 24.61 | 45.85 | |
4,025.80 | 44,223.40 | 96.68 | 4,387.70 | -25.09 | 435 | 57.50 | 61.92 | |
2,069.20 | 28,222.40 | #1 40.86 | 7,757.90 | -3.26 | 811 | -51.46 | 56.16 | |
474.20 | 23,410.40 | 42.15 | 4,664.30 | #1 10.33 | 555 | 34.98 | 61.29 | |
5,168.30 | 22,371.30 | 48.87 | #1 13,843.30 | - | 563 | -83.27 | 70.25 | |
4,287.70 | 21,255.60 | 73.69 | 2,120.90 | 0.37 | 271 | 34.94 | 46.72 | |
7,203.00 | 21,206.90 | 43.83 | 4,783.90 | -13.69 | 324 | #1 121.26 | 73.70 | |
1,848.70 | 19,164.70 | 47.37 | 1,938.80 | -8.77 | 323 | 18.04 | 65.03 | |
469.30 | 17,013.10 | 51.70 | 6,380.70 | -3.61 | 417 | -27.27 | 60.26 |
Forecast
Actual
Growth Rate
Revenue Growth
-18.85 %
Net Income Growth
-18.18 %
Cash Flow Change
-53.42 %
ROE
-71.22 %
ROCE
-56.77 %
EBITDA Margin (Avg.)
17.69 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 8 | 16 | 21 | 27 |
| Fixed Assets | 0 | 0 | 2 | 3 |
| Current Assets | 8 | 15 | 16 | 18 |
| Capital Work in Progress | 0 | 0 | 2 | 6 |
| Investments | 0 | 0 | 0 | 0 |
| Other Assets | 8 | 15 | 17 | 18 |
| Total Liabilities | 8 | 16 | 21 | 27 |
| Current Liabilities | 6 | 10 | 13 | 9 |
| Non Current Liabilities | 1 | 2 | 3 | 3 |
| Total Equity | 1 | 4 | 5 | 15 |
| Reserve & Surplus | 1 | 4 | 2 | 11 |
| Share Capital | 0 | 0 | 3 | 4 |
Cash Flow
| Cash Flow | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | -0 | 0 | 0 | 0 |
| Investing Activities | -0 | -0 | -5 | -5 |
| Operating Activities | -1 | -4 | 2 | 1 |
| Financing Activities | 1 | 4 | 3 | 4 |
Share Holding
| % Holding | Sept 2023 | Mar 2024 | Sept 2024 | Mar 2025 |
| Promoter | 73.02 % | 73.02 % | 73.02 % | 73.02 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 24.32 % | 24.08 % | 24.04 % | 24.00 % |
| Others | 2.67 % | 2.91 % | 2.94 % | 2.98 % |
| No of Share Holders | 641 | 506 | 438 | 422 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
No dividends have been distributed by the company in the past 10 years
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 13 Nov 2024 |  Quarterly Result Announcement | NA | 13 Nov 2024 | 58.45 | 54.00 |
| 30 Sept 2024 |  Annual General Meeting | NA | 30 Sept 2024 | 62.70 | 58.25 |
Technical Indicators
RSI(14)
Neutral 46.98
ATR(14)
Volatile 2.95
STOCH(9,6)
Neutral 55.79
STOCH RSI(14)
Overbought 81.86
MACD(12,26)
Bullish 0.49
ADX(14)
Weak Trend 11.45
UO(9)
Bearish 39.68
ROC(12)
Uptrend And Accelerating 14.53
WillR(14)
Neutral -50.46
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
